Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10786-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10786-1-AP, RRID:AB_2209130
- Product name
- TRIM9 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated TRIM9 antibody (Cat. #10786-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references The E3 ubiquitin ligase TRIM9 regulates synaptic function and actin dynamics in response to netrin-1.
A twin UGUA motif directs the balance between gene isoforms through CFIm and the mTORC1 signaling pathway.
Knockdown of TRIM9 attenuates irinotecan‑induced intestinal mucositis in IEC‑6 cells by regulating DUSP6 expression via the P38 pathway.
A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease.
TRIM9 short isoform preferentially promotes DNA and RNA virus-induced production of type I interferon by recruiting GSK3β to TBK1.
Promoter methylation of TRIM9 as a marker for detection of circulating tumor DNA in breast cancer patients.
TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson's disease and dementia with Lewy bodies.
McCormick LE, Evans EB, Barker NK, Herring LE, Diering GH, Gupton SL
Molecular biology of the cell 2024 May 1;35(5):ar67
Molecular biology of the cell 2024 May 1;35(5):ar67
A twin UGUA motif directs the balance between gene isoforms through CFIm and the mTORC1 signaling pathway.
Herron RS, Kunisky AK, Madden JR, Anyaeche VI, Maung MZ, Hwang HW
eLife 2023 Sep 4;12
eLife 2023 Sep 4;12
Knockdown of TRIM9 attenuates irinotecan‑induced intestinal mucositis in IEC‑6 cells by regulating DUSP6 expression via the P38 pathway.
Zhao W, Wang Q
Molecular medicine reports 2021 Dec;24(6)
Molecular medicine reports 2021 Dec;24(6)
A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease.
Seyfried NT, Dammer EB, Swarup V, Nandakumar D, Duong DM, Yin L, Deng Q, Nguyen T, Hales CM, Wingo T, Glass J, Gearing M, Thambisetty M, Troncoso JC, Geschwind DH, Lah JJ, Levey AI
Cell systems 2017 Jan 25;4(1):60-72.e4
Cell systems 2017 Jan 25;4(1):60-72.e4
TRIM9 short isoform preferentially promotes DNA and RNA virus-induced production of type I interferon by recruiting GSK3β to TBK1.
Qin Y, Liu Q, Tian S, Xie W, Cui J, Wang RF
Cell research 2016 May;26(5):613-28
Cell research 2016 May;26(5):613-28
Promoter methylation of TRIM9 as a marker for detection of circulating tumor DNA in breast cancer patients.
Mishima C, Kagara N, Matsui S, Tanei T, Naoi Y, Shimoda M, Shimomura A, Shimazu K, Kim SJ, Noguchi S
SpringerPlus 2015;4:635
SpringerPlus 2015;4:635
TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson's disease and dementia with Lewy bodies.
Tanji K, Kamitani T, Mori F, Kakita A, Takahashi H, Wakabayashi K
Neurobiology of disease 2010 May;38(2):210-8
Neurobiology of disease 2010 May;38(2):210-8
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- mouse brain tissue were subjected to SDS PAGE followed by western blot with 10786-1-AP(TRIM9 antibody) at dilution of 1:1000
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The TRIM9 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human TRIM9. This antibody recognizes human,mouse,rat antigen. The TRIM9 antibody has been validated for the following applications: ELISA, WB, IHC analysis.